Group 1 - The company, Man Kwan Group, has entered into a subscription agreement with Jacobson Group Treasury Limited to issue 94 million shares at a subscription price of HKD 0.5 per share, which represents 11.75% of the company's existing share capital as of the announcement date [1][2] - The total proceeds from the subscription are expected to be HKD 47 million, with a net amount of approximately HKD 46.7 million after expenses, intended for investment in core business growth, supply chain and logistics improvement, and general working capital [1][2] - The board believes that the subscription will enhance the financial position of the group and provide operational funds for future developments and obligations, with the subscriber intending to hold the equity long-term [2] Group 2 - The collaboration with Jacobson Group, a leading pharmaceutical company, is expected to create strategic synergies, leveraging both parties' expertise in healthcare and health products [2] - The subscription agreement is considered to be on normal commercial terms and is deemed fair and reasonable, aligning with the overall interests of the company and its shareholders [2] - The partnership aims to capitalize on emerging market opportunities, optimize financial leverage, and ultimately enhance long-term shareholder value [2]